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Zebraﬁshranscriptional events that regulate neural fate in response to extracellular signals
such as Bmps and Fgfs. Sox3 is one of the earliest transcription factors to be expressed in the developing CNS
and has been shown to be regulated by these signalling pathways. We have used both gain- and loss-of-
function experiments in zebraﬁsh to elucidate the role of Sox3 in determining neural fate. Ectopic Sox3
caused induction of neural tissue from a very early stage of cell speciﬁcation in the ectoderm and this effect
was maintained such that large domains of additional CNS were apparent, including almost complete
duplications of the CNS. Knock-down of Sox3 using morpholinos resulted in a reduction in the size of the
CNS, ears and eyes and subsequent inhibition of some aspects of neurogenesis. Our data also suggest that the
pro-neural effects of Sox3 can compensate for inhibition of Fgf signalling in inducing neural tissue but it is
not sufﬁcient to maintain neural fate, suggesting the presence of Sox3-independent roles of Fgf at later
stages.
© 2008 Elsevier Inc. All rights reserved.Introduction
Neural development in vertebrates occurs in cells of the ectoderm
in response to a range of intercellular signals, including the Bmps, Fgfs
and Wnts (Stern, 2006; Wilson and Edlund, 2001). The balance of
these signals results in cells adopting either a neural or non-neural
fate. This response involves complex changes in gene expression
mediated by altered activity of speciﬁc transcription factors. Despite
many years of analysis, the relative roles of these different pathways is
only now becoming clear and the link between the activation or
repression of these pathways and speciﬁc transcription factor
activities to elicit a neural response is poorly understood. This is
reﬂected by the small number of transcription factors for which there
is evidence of a direct role in mediating this response.
Sox3 is one of the earliest and most generally expressed
transcription factors in neural development of vertebrates (Penzel et
al., 1997; Rex et al., 1997; Wood and Episkopou, 1999; Zhang et al.,
2004, 2003). Along with the other SoxB1 factors, Sox1 and Sox2, Sox3
has been implicated as a central player in themaintenance of the stem
cell state of neural cells (Bylund et al., 2003; Graham et al., 2003). Sox3
expression requires active Fgf signalling but it is generally repressed
where Bmp signalling is active (Dee et al., 2007; Heeg-Truesdell and
LaBonne, 2006; Kudoh et al., 2004; Rentzsch et al., 2004; Streit et al.,Scotting).
r.
ge London, De Crespigny Park,
edicine, University of Oxford,
K.
l rights reserved.2000). However, sox3 is also expressed prior to the partitioning of
ectoderm into neural and non-neural domains (Dee et al., 2007; Rex et
al., 1997). Despite its unique position as the earliest of the SoxB1 genes
to be expressed, relatively little is known of the function and
mechanism of Sox3 in neural development.
All three SoxB1 factors have also been shown to be able to impede
the differentiation of neural stem cells in the spinal cord, while a
construct that repressed target genes led to premature differentiation
(Bylund et al., 2003; Graham et al., 2003). However, their role in the
earlier fate choice of ectodermal cells to adopt a neural fate is less well
understood. Loss of Sox3 in mice appears to generate a relatively mild
phenotype. Although initial studies in an inbred strain of mice showed
loss of Sox3 to be lethal as early as gastrulation, the genetic
background proved to be critical, and later experiments using out-
bred mice produced phenotypes varying from apparent wild-type to
mild defects in brain and germ cell development (Rizzoti et al., 2004).
In chick, although its expression is rapidly induced by the node or FGF
signalling (Streit et al., 2000), the role of Sox3 in the central nervous
system (CNS) has not been elucidated. In the peripheral nervous
system (PNS), we have shown that Sox3 induces ectopic placode-like
thickening (Abu-Elmagd et al., 2001) as has been described in Medaka
(Koster et al., 2000). A role in even earlier events was demonstrated by
Zhang et al. (2003, 2004) in which Sox3 appears to play a role in
repressing mesendoderm formation. In Drosophila there are two SoxB
genes, SoxNeuro and Dichaete, which have both been implicated in
dorsoventral patterning of the neuroectoderm and subsequent
neurogenesis (Girard et al., 2006; Overton et al., 2002; Zhao and
Skeath, 2002). These data suggest that Sox3 is likely to play an early
and central role in the choice of ectoderm to adopt a neural fate as well
as regulating later neuronal differentiation.
Fig. 1. Sox3 over-expression causes expansion of neural tissue. Wild-type control
embryos (A–D) and embryos injected with sox3 mRNA at 16–32 cell stage (E–L) are
viewed dorsally aged 24 hpf. (E, I) Injection of sox3 mRNA causes development of extra
neural tissue visible in the live embryo (bars indicate unaffected and expanded sides of
the CNS, E), and GFP ﬂuorescence indicates this occurs in the region expressing
exogenous sox3 (I). (F, J) Live embryo showing over-expression of sox3 causing loss of
eye (arrow, F) when expressed in the rostral region of the CNS seen by GFP ﬂuorescence
(J). (C, D, G, H, K, L) In situ hybridisation for expression of neural markers ncad or sox2 in
wild-type embryos (C, D) and embryos injected with sox3 mRNA (G, H, K, L) shows the
development of ectopic tissue either within the brain (arrow, G; asterisks indicate
multiple neural epithelia in panel H, 16/68 embryos), expansion of the brain (K, 2/21) or
expansion of a local region of the trunk (arrow, L, 4/47).
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zebraﬁsh using both gain-of-function and loss-of-function
approaches. We show that ectopic expression of Sox3 leads ectoderm
to acquire neural fate, with appearance of the earliest neural markers
and expansion of the later neuroepithelium. Likewise, we observed
loss of neural structures when Sox3 was knocked-down by morpho-
lino injection. We also show that Sox3 can compensate for absence of
Fgf signalling during the initiation of neural fate, but it is insufﬁcient to
compensate for later roles of Fgf signalling. In addition, we ﬁnd that
Sox3 is essential for subsequent neuronal differentiation, in both the
CNS and PNS, and for normal development of the eye and ear.
Methods
Generation of constructs
A morpholino-sensitive sox3-GFP fusion construct (MSsox3-GFP) was produced to
assess the efﬁcacy of Sox3 morpholinos. The coding sequence of sox3 and 189 bp of 5′
UTR, was ampliﬁed from zebraﬁsh 70% epiboly stage cDNA by PCR using the Superscript
III kit (Invitrogen) and the following primers: forward 5′-CCATCGATAGCTTAGCGCA-
CAACTTT-3′ and reverse 5′-GCTCTAGAAATGTGGGTTAGGGGTAG-3′. The resulting
product was ligated into the pCR-II vector (Invitrogen) and subcloned into the
pCS2nlsGFP (gift from Dr. Marie-Anne J. O'Reilly) vector at the ClaI–XbaI site so that the
ﬁnal construct contains an in-frame fusion of sox3 and GFP (with the nuclear
localization signal and myc sequences of the parental vector removed).
Injection of RNA and morpholinos
Zebraﬁsh embryos were collected and staged according to standard methods
(Kimmel et al., 1995; Westerﬁeld, 2000). Capped mRNAs for microinjection were
produced from linearised cDNA template using mMessage-Machine kits (Ambion)
according to the manufacturer's instructions.
Antisense morpholino oligonucleotides (MOs) designed to target the 5′ region of
sox3 were obtained from Genetools (Philomath, OR). The MO sequences were:
sox3MO1 5′-GGTGCCAAGCACTCGAAAGAAAACG-3′, and sox3MO2 5′-CCATCATGTTATA-
CATTCTTAAAAG-3′. Embryos were injected with a mixture of sox3MO1 (2.5 ng) and
sox3MO2 (2.5 ng) in 0.5 nl volume at the 1–2 cell stage. The 5 bp mis-match
(represented in lower case) control MO sequences were: sox3MO1-5 mm 5′-
GGTcCCAAcCAgTCGAAAcAAAAgG-3′, and sox3MO2-5 mm 5′-CgATCATcTTATAgATTgT-
TAAAtG-3′. Effective MO knock-down was tested by co-injecting with mRNA encoding
MSsox3-GFP (125 pg).
Transplantations
Donor embryos were injected at the 1–2 cell stage with a mixture of sox3 (50 pg)
(including an HA tag) and GFP (50 pg) mRNA and cells removed at the oblong stage
using amicroelectrode connected to a 1ml BD Plastipak syringe as previously described
(Kane and Kishimoto, 2002). Donor cells were then introduced into the animal pole of
similar stage wild-type host embryos, and the resulting embryos incubated in E2 buffer
(15 mM NaCl, 0.5 mM KCl, 1 mM CaCl2, 1 mM MgSO4, 0.15 mM KH2PO4, 0.05 mM
Na2HPO4, 0.7 mM NaHCO3) until time of collection. Following in situ hybridisation,
transplanted cells were detected using rabbit polyclonal anti-HA ab9110 (1:2000;
AbCam), anti-rabbit IgG HRP labelled secondary (1:2000; Vector labs) and visualized
with DAB substrate (Vector labs).
TUNEL staining
Embryos were dechorionated at 24 hpf, ﬁxed in 4% paraformaldehyde for 1 h at
room temperature, dehydrated and stored at −20 °C over night. Following rehydration,
embryos were treated with proteinase K (10 μg/ml in PBS) for 20 min at room
temperature, and washed in PBS. TUNEL staining was then performed using an In Situ
Cell Death Detection Kit, Fluorescein (Roche) according to the manufacturer's
instructions. Images were captured using a Leica SP2 CLSM confocal microscope.
SU5402 treatments
SU5402 (Calbiochem) was dissolved in DMSO to give a 3.36mM stock solution. This
was used at a ﬁnal concentration of 84 μM in ﬁsh water containing methyl blue.
Embryos were treated at 28 °C, in the dark from the 512 cell stage until the required
time of collection. Negative control embryos were treatedwith an equivalent dilution of
DMSO.
Whole-mount in situ hybridisation and immunohistochemistry
Whole-mount in situ hybridisation was carried out as previously described (Jowett
and Yan, 1996) using the following Digoxigenin (DIG)-labelled (Roche) riboprobes: sox2
(Dee et al., 2007), sox31 (Girard et al., 2001), gata2 (Read et al., 1998), ncad (Lele et al.,
2002), pax2a (Krauss et al., 1991), pax8 (Pfeffer et al., 1998), ngn1 (Sun et al., 2007),phox2a (Guo et al., 1999), foxd3 (Stewart et al., 2006), snai1b (Stewart et al., 2006), ntl
(Schulte-Merker et al., 1992), shha (Krauss et al., 1993), emx1 (Morita et al., 1995),
krox20 (Sun et al., 2007), otx2 (Mori et al., 1994), hoxb1b (EST obtained from RZPD:
bq985541), elavl3 (IMAGE: 7062042), elavl4 (IMAGE: 6967800), nefm (IMAGE:
6968572). Alkaline phosphatase conjugated DIG antibody was detected using BM-
purple (Roche). For the double in situ hybridisation, a ﬂuorescein-labelled (Roche) ntl
riboprobe was used and detected using alkaline phosphatase conjugated anti-
ﬂuorescein (Roche) and Fast Red (Sigma-Aldrich). To detect GFP, immunostaining was
performed according to standard protocols using ﬂuorescein conjugated anti-GFP
(Ab6662, 1/1000; AbCam), and an alkaline phosphatase conjugated anti-ﬂuorescein
secondary antibody (Roche) visualized using Fast Red (Sigma-Aldrich). For sectioning
after in situ hybridisation, embryos were dehydrated, transferred to ethanol and
embedded in JB4 methacrylate (Agar Scientiﬁc) for microtome (Leica RM2265)
sectioning. Sections were mounted in Vectashield mounting medium with DAPI
(Vector Laboratories). Sections were taken immediately caudal to the eye or posterior
branchial arches (marked by hoxb1b) and the average cell count from 7 sections (10 μm
thickness for brain or 12 μm for spinal cord) was taken.
Levels of Sox3 expressionwere assayed on frozen sections as follows. Embryoswere
soaked in 15% sucrose and embedded in 7.5% gelatin/15% sucrose. Blocks were frozen in
isopentane and sectioned at 10 μm thickness onto Superfrost Plus (VWR international)
slides. Antigen retrieval was carried out by ﬁxing embryos in 4% paraformaldehyde then
dehydrating in methanol overnight. Rehydrated embryos were treated with citrate
buffer (10 mM citric acid, pH6) at 4 °C for 1 h, then transferred to citrate buffer at 100 °C
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cryostat sections of 24 hpf embryos. Sections were blocked in 5% goat serum (Sigma)
then incubated with primary antibody (anti-Sox3 1:200; Bylund et al., 2003) in the
same blocking solution at 4 °C overnight. Sections were then washed in PBT, incubated
in secondary antibody Alexa Fluor 488 (Invitrogen) for 2 h at room temperature, then
washed in PBT treated in DAPI (Invitrogen) and mounted in Mowiol mounting medium
(Sigma-Aldrich).
Western blot
Embryos were collected at 70% epiboly, dechorionated by hand and deyolked as
previously described (Link et al., 2006). Aliquots of protein (each equivalent to 15
embryos) were resolved on an 11% SDS-PAGE gel and transferred to Hybond-C extra
nitrocellulose membrane (Amersham). The primary antibodies used were FL-
conjugated anti-GFP (1:1000; AbCam) and anti-Actin (1:2000; Sigma). The secondary
antibody was an anti-goat or anti-rabbit IgG horseradish peroxidase-conjugated FAB
fragment (1:5000; Vector Labs). Signals were detected using an ECL-plus kit
(Amersham) and emitted light was detected by exposure to ﬁlm (Kodak).
Results
Sox3 induces ectopic neural tissue and duplications of the central
nervous system
In order to investigate the role of Sox3 in the decision of cells to
acquire a neural fate in the early ectoderm, we adopted a gain-of-
function strategy, over-expressing full-length zebraﬁsh sox3. This
approach generated striking phenotypes demonstrating that ectopic
Sox3 is sufﬁcient to cause cells of the ectoderm to adopt a neural
fate.
Previous studies in Xenopus and zebraﬁsh have demonstrated a
role for maternal Sox3 in the regulation of early germ layer formation,
negatively regulating the expression of nodal-related genes critical for
mesendoderm development (Zhang et al., 2004). Clearly, such a
signiﬁcant effect on the formation of mesoderm tissue, which is the
source of potent neural-promoting signals, would complicate the
interpretation of any phenotypes observed in the ectoderm. In order
to examine the effects of Sox3 in the ectoderm, we therefore injected
sox3 mRNA at the 16–32 cell stage, targeting the animal pole so that
most injected cells would contribute to the future ectoderm. We co-
injected mRNA encoding GFP as a lineage tracer allowing the progenyFig. 2. Sox3 over-expression causes expansion of the neural plate. All embryos are viewed fr
(A–F) Wild-type controls. (G–L) Embryos co-injected with sox3mRNA and GFP mRNA (lineag
protein (red colour). Sox3 over-expression causes neural plate markers ncad and sox2 to expa
30) and snai1b (J, P, 22/39) and pre-placodal ectoderm; pax2a (K, Q, 14/30) and pax8 (L, R, 1of the injected cells to be identiﬁed using immunostaining for the GFP
protein.
Embryos over-expressing Sox3 in this way exhibited a variety of
phenotypes localized to the Sox3 over-expressing region of the
embryos. In all cases, the phenotypes indicated that exogenous Sox3
caused the development of additional neural tissue. These phenotypes
could be seenmost clearly when stained for the expression of neurally
expressed genes such as n-cadherin (ncad) (Figs. 1C, G, K) or sox2 (Figs.
1D, H, L). Most commonly, we observed regions of ectopic neural
tissue within the head or trunk of the embryo (Figs. 1E, G, and H), in
some cases appearing as a duplicated regionwithin the brain (Fig. 1H).
Expansion of the CNS such as a broadening of the head (Fig. 1K), or a
localized expansion in the trunk (Fig. 1L), was also seen. In addition,
expression of exogenous Sox3 in the anterior region of the brain often
resulted in the loss (or reduced size) of one or both eyes (Figs. 1F, J).
In order to assess the effect of Sox3 on neural fate in more detail,
we examined the effect of ectopic Sox3 at the 3 somite stage, when the
neural plate has just become clearly established and can be visualized
by the expression of neural markers such as ncad and sox2. Ectopic
expression of Sox3 consistently resulted in expansion of both of these
neural plate markers (Figs. 2G, H, M, N) as compared to wild-type
control embryos (Figs. 2A, B). In addition, we examined the expression
of markers of the neural crest (foxd3 and snai1b) and pre-placodal
ectoderm (PPE; pax2a and pax8), which lie at the border of the neural
plate (Figs. 2C–F). In embryos exhibiting expansion of the neural plate,
these markers were displaced laterally (Figs. 2I–L, O–R). Occasionally,
when the patch of ectopic Sox3 was in a broad region adjacent to the
normal neural plate overlying the prospective placodal domain, we
saw loss of pax2a or pax8 expression (data not shown).
In a small number of embryos, the patch of Sox3 over-expression
was almost separate from the endogenous CNS. In such embryos, a
partial second axis formed, most evident through the expression of
the neural crest markers, foxd3 (Figs. 3A–C) and snai1b (Figs. 3D–F).
Signiﬁcantly, at the 24 hpf stage, a similar small number of embryos
showed striking duplications of portions of the brain or spinal cord
(Figs. 3G–Q). This can be seen clearly in embryos stained for the
expression of ncad (Figs. 3G–I) and sox2 (Figs. 3J–L), but also includes
duplication of the positional fate marker pax2a, which is expressed atom the dorsal side at the 3-somite stage. Markers for in situ hybridisation are indicated.
e tracer) at 16–32 cell stage. (M–R) The same embryos immunostained to detect the GFP
nd locally (G, M, 29/47 embryos, H, N, 32/39). Markers of the neural crest; foxd3 (I, O, 12/
6/32) are displaced laterally.
Fig. 3. Over-expression of Sox3 can cause duplications of the CNS. (A–F) Dorsal view
of embryos at the 3 somite stage. (A, D) Control wild-type embryos showing
expression of neural crest markers foxd3 (A) and snai1b (D) ﬂanking the neural
plate. (B, E) Embryos injected with sox3 mRNA (and GFP mRNA lineage tracer) at
the 16–32 cell stage can generate a partial second axis ﬂanked by foxd3 (B, 4/30
embryos) or snai1b (E, 2/39) expression. Immunostaining for GFP (red colour) shows
this to correspond to the injected region (C, F). (G–Q) Embryos viewed dorsally aged
24 hpf. (G, J, M, P) Wild-type control embryos. (G–L) In situ hybridisation for the
expression of neural markers ncad (G–I) and sox2 (J–L) reveals that injection of sox3
mRNA at 16–32 cell stage can cause duplications of the CNS in the head (H, 2/21, K,
5/47) or tail (I, 3/21, L, 14/47). (M–Q) Duplications are also seen of the hindbrain
marker krox20 (M–O, red colour, arrows indicate duplication, 8/43), the ﬂoor plate
marker shha (M–O, blue colour) and pax2a which is expressed at the midbrain/
hindbrain boundary (arrows, P, Q).
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expressed in rhombomeres 3 and 5 of the hindbrain (Figs. 3M–O, seen
as red colour). The duplication of sonic hedgehog a (shha), which is
expressed in the ventral midline of the CNS, veriﬁed that this was
genuine duplication rather than just broadening of the CNS (Figs. 3M–
O, seen as blue colour).
Ectopic Sox3 expression causes activation of neural fate markers and
repression of non-neural fate markers in the early ectoderm
Neural induction begins during gastrulation, when a number of
intercellular signalling events, including the Bmp, Fgf and Wnt
pathways, act to deﬁne the neural and non-neural ectoderm. Given
the effect of ectopic Sox3 at later stages of development, we set out to
determine if this was due to cells adopting a neural fate ectopically at
this initial stage of neural induction.
Injection of sox3 mRNA at the 1–2 cell stage caused expansion of
the early neural fate markers sox2 and sox31 at 70% epiboly, the time
when neural ectoderm is ﬁrst established (Figs. 4A, D, B, E). In
addition, a reciprocal repressive effect was seen on gata2, a marker of
non-neural fate (Figs. 4C, F). This result is strikingly similar to the
neural inducing effect of ectopic Fgf signalling at the same develop-
mental stage (Dee et al., 2007; Kudoh et al., 2004; Rentzsch et al.,
2004).
Since Sox3 disrupts mesoderm formation, the changes in ectoder-
mal fate seen after injection at the 1–2 cell stage could be secondary
effects due to altered signalling from the mesoderm. We therefore
injected sox3 mRNA at the 16–32 cell stage, targeting the injection to
the animal pole, so that most over-expressing cells would contribute
to the future ectoderm. As before, mRNA encoding GFP was co-
injected as a lineage tracer (Figs. 4J–L). Local ectopic Sox3 expression
once again caused strong induction of the neural fate markers sox2,
sox31 (Figs. 4G, H, J, K) whilst causing repression of the non-neural
fate marker, gata2 (Figs. 4I, L). The correlation between GFP expression
and ectopic activation of the endogenous genes suggests that this
effect is cell autonomous. In order to ensure that Sox3 was able to
induce these effects in the absence of effects onmesoderm, we carried
out double in situ hybridisation to assess the mesoderm marker, no-
tail (ntl) when sox31 was induced by ectopic Sox3. This showed that
the neural marker sox31 could be reproducibly induced in the absence
of ectopic ntl, when endogenous mesoderm development also
appeared entirely normal (Figs. 4M–P). However, injection of RNA at
the 16–32 cell stage occasionally resulted in cells outside of the
ectoderm also expressing the ectopic gene. We therefore carried out
cell transplantation experiments. This allowed the cells to be localized
to the ectoderm at an even later stage, oblong, when several thousand
cells were present ensuring that the injected population of cells was
localized entirely to the ectoderm. This again resulted in ectopic
expression of sox2 and sox31 in the region of the transplanted cells
(Figs. 4Q–X). The ectopic neural markers coincided with the
transplanted cells over-expressing Sox3, as labelled by immunostain-
ing for the HA tag of the ectopic Sox3 (seen as dark brown colour in
Figs. 4R, T, V and X) again strongly supporting the view that this effect
was cell autonomous and mediated directly within the ectoderm.
Hence, from the earliest stages when these choices are established,
over-expression of Sox3 appears able to respecify ectoderm to a neural
fate via a cell autonomous and mesoderm-independent mechanism.
This fate is then maintained into later stages of development.
Loss of Sox3 function results in reduced neural ectoderm
Although the gain-of-function experiments described above
indicate that Sox3 can affect the ectoderm and result in the induction
of ectopic neural tissue, this does not clarify whether endogenous
Sox3 plays a role in neural development. In order to determine if Sox3
function is necessary for normal neural development, we used
Fig. 4. Sox3 promotes neural fate in the early ectoderm. Lateral view of mid-gastrula embryos with dorsal to the right unless otherwise indicated. The prospective neural fate markers
sox2 and sox31, and the prospective non-neural fatemarker gata2 detected by in situ hybridisation are indicated at the top of panels. (A–C) Control wild-type embryos. (D–F) Injection
of embryos with sox3 mRNA at the 1–2 cell stage causes expansion of the prospective neural ectoderm marked by sox2 (D, 42/77 embryos) and sox31 (E, 29/48) and loss of
prospective non-neural ectoderm marked by gata2 (F, 13/29). (G–I) Injection of sox3mRNA (with GFP mRNA lineage tracer) at the 16–32 cell stage causes ectopic expression of sox2
(G, 39/76) and sox31 (H, 13/24) and repression of gata2 (L, 41/76) in the injected region. (J–L) Immunostaining for GFP reveals the ectopic Sox3 expressing region (red colour). (M–P)
Double in situ hybridisation for the expression of sox31 (blue) and ntl (red, appears brown when overlapping with blue stain). (M) Control wild-type embryo. (N–P) Lateral, animal
pole and dorsal view of the same sox3 (16–32 cell) injected embryo. Ectopic sox31 is induced whilst the mesoderm marker ntl is unaffected (15/57). (Q–X) Views of wild-type
embryos inwhich donor cells (dark brown) over-expressing HA-tagged Sox3were transplanted to the animal pole at oblong stage. Transplanted, Sox3-expressing cells exhibit ectopic
expression of the neural markers sox2 (Q–T, 5/5) and sox31 (U–X, 7/7) in a cell autonomous manner. Staining of embryos with anti-HA (dark brown) reveals the position of the
transplanted cells (R, T, V, X) showing they are coincident with the ectopic marker expression.
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function by blocking translation of the endogenous sox3 transcripts.
Two different MOs were designed; sox3MO1 targeted the 5′UTR and
sox3MO2 targeted the translation start site (Fig. 5A). In addition, wedesigned two corresponding 5 bp mis-match MOs as speciﬁcity
controls (Fig. 5A). In order to test whether these morpholinos could
effectively knock-down translation of a sox3 transcript, we used an
anti-Sox3 antibody raised against chick Sox3 (Bylund et al., 2003) on
Fig. 5. Sox3 expression is inhibited by MO injection. (A) Sequence of sox3 5′UTR with MO binding sites labelled. Start codon indicated in bold and the positions of control MO mis-
matches are indicated by asterisks. (B) Sections taken from the head of 24 hpf embryos and stained with anti-Sox3 and DAPI. A profound reduction of Sox3 protein expression is seen
in embryos co-injected with sox3MO1/2 as compared to wild-type controls. (C) Co-injection of sox3MO1/2 blocked translation of a co-injected sox3-GFP fusion containing the MO
target sequence as assayed by GFP ﬂuorescence examined at 50% epiboly but had no effect on GFP alone. (D) Extent of knock-down of GFP fusions assayed byWestern blot to detect
the GFP protein. Actin was used as a loading control for the Western blot. Injection of sox3MO1 or sox3MO2 individually can be seen to knock-down sox3 translation less effectively
than when used in combination. Control MOs (sox3mmMO1/2) could not block translation of sox3-GFP.
294 C.T. Dee et al. / Developmental Biology 320 (2008) 289–301frozen sections following antigen retrieval (Fig. 5B). These data show
that the endogenous Sox3 protein is clearly reduced in MO injected
embryos, demonstrating that a combination of sox3MO1 and
sox3MO2 can effectively inhibit translation of the sox3 transcript. In
order to gain a more quantitative assessment of the effectiveness of
these MOs to knock-down Sox3, we designed a sox3-GFP fusion
construct containing the entire 5′UTR and the coding sequence of
sox3. We were able to demonstrate that both sox3MO1 and sox3MO2
were able to strongly inhibit the translation of sox3-GFP (assayed by
GFP ﬂuorescence or Western blot), but found that injection of both
MOs together caused even more effective reduction of protein level
(Figs. 5C, D). Indeed, in practice we found co-injection of a mixture of
the twoMOs generated the strongest andmost robust phenotypes and
both were used in all subsequent experiments. As expected, these
morpholinos had no effect on the translation of GFP mRNA lacking
Sox3 sequences (Figs. 5C, D) and mis-match control MOs had no effect
on translation of the Sox3-GFP fusion transcript (Figs. 5B, C).
The presence of maternally contributed SoxB1 proteins during
early development (Zhang et al., 2004) suggests that MO knock-down
of zygotic transcript might not generate severe phenotypes in the
earliest stages of development. Indeed, our initial experiments with
the sox3MOs found little or no effect on the expression of genes in the
early (gastrula) ectoderm (data not shown). However, injection of
sox3MOs did result in abnormal development of the neural ectoderm
at later stages, suggesting a requirement for sox3 in the proliferating
neural epithelium. Morphants at the 24 hpf stage exhibited a range ofgross morphological phenotypes as compared to wild-types or mis-
match control MOs (Fig. 6A). These ranged from those which died or
had little recognizable morphology with loss or fragmentation of the
caudal CNS (Fig. 6Aii, 93/307 injected embryos) through those with a
signiﬁcantly shortened body axis (Fig. 6Aiii, 135/307) to milder
phenotypes characterised by less severe loss of caudal tissues (Fig.
6Aiv, 79/307). In all cases, therewas a profound reduction in the size of
CNS structures. This was very striking in the head region, and could be
seen clearly in embryos stained for the expression of sox2 or ncad
(Figs. 6B, C). Often one or both of the eyes were reduced in size or lost
completely (Figs. 6Bii, Cii). To conﬁrm the speciﬁcity of the
phenotypes, MOs were co-injected with a relatively low dose
(25 pg) of sox3 mRNA, which lacks the endogenous 5′UTR and is
therefore relatively insensitive to the MOs. As expected, co-injection
of sox3 mRNA resulted in rescue of morphant phenotypes in the
majority (91/113) of injected embryos (Figs. 6Av, Biii, Ciii).
To further examine the morphant phenotype, we cut transverse
sections of 24 hpf morphant ﬁsh and compared these to thewild-type.
In the brain there was an almost complete lack of ventricular lumen
(Fig. 6D) such that the structure resembled a thickened spinal cord.
However, there was some morphological evidence that the hindbrain
retained its identity. In wild-type embryos the hindbrain is expanded
to leave a broad but thin roof plate, which is exclusive to the hindbrain
region (Fig. 6Ei). The equivalent region of the morphant embryos was
seen still to exhibit a very thin roof plate, despite the lack of an enlarged
lumen (Fig. 6Eii). In order to assess whether there was a difference in
Fig. 6. Sox3 knock-down causes reduced neural tissue in the CNS. (A–C) In situ hybridisation of 24 hpf embryos showing the expression of the neural markers sox2 (A, B) and ncad (C).
(A) Lateral views. (B, C) Dorsal views. Embryos injected with mis-match control MOs (mmMOs) are indistinguishable fromwild-type (Ai, Bi, Gi). Injection of sox3MOs causes severe
loss of neural structures in the brain and loss of caudal tissues (Aii: 25/307, Aiii: 135/307, Aiv: 67/307) and the remaining neural tissue of the head is disorganised but continues to
express sox2 (Bii) and ncad (Cii) strongly. The MO phenotype is rescued by co-injection with sox3mRNA (Aiii, Biii, Ciii: 91/113). (D, E) Transverse sections cut in the midbrain (D) and
hindbrain (E) viewed under white light (Di, Dii, Ei, Eii) or DAPI stain (Diii, Div, Eiii, Eiv) showing loss of lumen (indicated by asterisk, Diii, iv) and reduced hindbrain (roof plate
indicated by arrow, Ei, ii) in sox3morphant embryos. (F) Transverse section cut of the spinal cord of control (Fi–iii) or morphant (Fiv–vi) embryos viewed under white light (Fi, ii, iv, v)
or DAPI stain (Fiii, iv). (Fi, iv) Lateral view of embryos showing position where sections were taken. Scale bars are equal to 100 μm (Di, Ei) or 50 μm (Fii). (G) Fluorescent images of
TUNEL stained 24 hpf embryos, lateral views. Signiﬁcant ﬂuorescent signal in morphant embryos (Gii, 11/11 compares to phenotype in Aiii) shows increased apoptosis compared to
wild-type controls (Gi). MO-induced apoptosis is rescued by co-injection with sox3 mRNA (Giii, 11/13). Position of the brain is marked by asterisks and the arrows indicate ventral
edge of the tail in wild-type and rescue embryos (Gi, iii).
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morphant ﬁsh following DAPI staining. We found a 43% decrease in
cell number in the brain and 37% decrease in the spinal cord (Figs. 6Diii,
iv, Eiii, iv). Fluorescent TUNEL staining revealed a signiﬁcant increase in
apoptosis throughout morphant embryos (Fig. 6Gii) when compared
to wild-type controls (Fig. 6Gi). This MO-induced apoptosis could be
rescued by co-injectionwith sox3mRNA (Fig. 6Giii) indicating that the
cell death is a speciﬁc effect of sox3 knock-down. Thus, the apparentreduction in size of the CNS seen in whole mount embryos was due
both to lack of a signiﬁcant lumen and a reduction in cell number, due
in part, at least, to programmed cell death.
Since the morphology of the brain was severely disrupted in
morphant ﬁsh, we examined the expression of a series of positional
markers within the CNS, to determine if these morphological effects
were due to incorrect positional speciﬁcation. Morphant and control
embryos were analysed for the expression of emx1, a marker of the
296 C.T. Dee et al. / Developmental Biology 320 (2008) 289–301telencephalon (Figs. 7A, F); otx2, a marker of rostral CNS (Figs. 7B, G);
pax2a, expressed at the midbrain/hindbrain boundary (Figs. 7C, H);
krox20, which is expressed in rhombomeres 3 and 5 of the hindbrain
(Figs. 7D, I); and hoxb1b which is expressed throughout the spinal
cord, caudal to the hindbrain (Figs. 7E, J). Morphant ﬁsh were found to
express all these markers in their normal positions, suggesting that
normal rostrocaudal patterning of the rostral CNS is retained when
Sox3 is depleted.
Sox3 is required for the initiation of neurogenesis
It has previously been shown in chick embryos that Sox3 acts to
prevent cells from undergoing neurogenesis in the spinal cord,
maintaining neural cells in an undifferentiated state. This effect is
downstream of chick Neurogenin2 (cNgn2). The expression of cNgn2 is
unaffected by Sox3 over-expression. However, sox3 expression is
repressed by over-expression of cNgn2, but Sox3 can itself block the
activation of later neurogenesis markers following over-expression of
cNgn2 (Bylund et al., 2003). However, this study did not assess if
Sox3 is necessary for neurogenesis. We therefore examined the
expression of several markers of differentiating neurons including
ngn1 (which, like cNgn2, is expressed in the CNS, otic and epibranchial
placodes) following MO injection. Loss of Sox3 resulted in substantial
reduction in the expression of ngn1 (Figs. 8A, F), phox2a (Figs. 8B, G),
elavl3 and elavl4 (which encode homologues of the mammalian
RNA-binding factors HuC and HuD respectively; Figs. 8C, D, H, I), and
neuroﬁlament medium chain (nefm) (Figs. 8E, J) throughout the CNS.
This effect wasmost dramatic in the head. Thus, it appears that Sox3 is
necessary for the expression of all of these markers of neuronal
differentiation. These effects are clearly not simply due to loss of neural
tissue, since there is substantial ncad/sox2-positive neural tissue in
these morphants (Figs. 6A–H), but these cells fail to undergo
differentiation in the absence of Sox3.
We also examined whether injection of Sox3 RNA affected
neurogenesis. We found that the timing and level of ngn1 (Fig. 8K),
elavl3 (Fig. 8M), elavl4 (Fig. 8N) and nefm (shown here at 48 h; Fig. 8O)
expressionwas maintained in both CNS and placodal tissue in embryos
over-expressing Sox3. Expressionof all of thesegeneswasalso seen tobe
associated with ectopically induced neural tissue. The expression of
phox2a, a marker expressed in a discrete population of differentiating
neurons in the CNS (in addition to the epibranchial placodes) was theFig. 7. Sox3 knock-down does not affect rostrocaudal patterning of the CNS. Control (A–E) an
the developing brain and spinal cord. Expression of positional markers is maintained in mor
49 embryos), otx2 (B, G, 10/10), pax2a (arrows indicate midbrain/hindbrain boundary; C, H,19
23/23). All embryos are aged 24 hpf and dorsal view except for panels E and J which are laonly marker that appeared disrupted, in both the CNS and placodal
regions (Fig. 8L). We also examined the expression of these markers at
the early stage of 18 hpf (with the exception of nefm, which is expressed
only weakly at this stage). We again found that only phox2a was
disrupted by Sox3 over-expression (Figs. 8Q, U), and that ngn1 (Figs. 8P,
T), elavl3 (Figs. 8R, V) and elavl4 (Figs. 8S,W)were all expressed strongly
in regions of ectopically induced tissue. Western blot analysis revealed
that the level of exogenous Sox3 protein declined rapidly, such that it
wasbarely detectable by18hpf andwasundetectable by24hpf (Fig. 8X).
Thus, the lack of effect of injected sox3RNAonmostmarkers of neuronal
differentiation might reﬂect the lack of exogenous Sox3 at these later
stages. The effect on phox2a seems likely to have resulted from an effect
at an earlier stage of development.
Sox3 is required for normal development of the ear and cranial placodes
In addition to expression in the CNS, we have previously shown
sox3 to be strongly expressed in the pre-placodal ectoderm where it
marks the region fated to become the ear and epibranchial placodes
(Sun et al., 2007). By 24 hpf, sox3 is more widely expressed in the
neurogenic placodes including the epibranchial, otic and trigeminal
placodes (Sun et al., 2007).
Following injection of the sox3 MOs at the 1–2 cell stage of
development, we saw a range of defects in otic vesicle development
ranging from reduced (Figs. 9B, F) and split (Figs. 9C, G) vesicles to
complete absence (Figs. 9D, H). It was noticeable that other aspects of
otic development such as the appearance of the otolith appeared
normal even when the ear was signiﬁcantly reduced in size or split
(see Figs. 9A–C).
Loss of sox3 also resulted in loss of expression of ngn1 and phox2a
in all of the placodes analysed including the otic and epibranchial
placodes (Figs. 9I–L). Thus, the effects upon neuronal differentiation
are equivalent to those seen in the CNS with over-expression
inhibiting the expression of phox2a downstream of ngn1, and loss-
of-function causing loss of expression of both phox2a and ngn1.
Sox3 can rescue some aspects of neural fate in the absence of Fgf
signalling
Our data indicate that Sox3 alone is sufﬁcient to predispose
ectoderm towards a neural fate. Since Sox3 expression in zebraﬁsh isd sox3morphant (F–J) embryos were stained for the expression of positional markers of
phant embryos despite severe disruption of CNS tissue. Markers used are emx1 (A, F, 42/
/22), krox20 (D, I, 14/14) and hoxb1b (arrows indicate rostral limit of CNS expression; E, J,
teral view.
Fig. 8. Sox3 is required for neuronal differentiation. (A–O) Dorsal view of in situ hybridised embryos aged 24 hpf unless otherwise indicated in the panel. Wild-type embryos (A–E)
were analysed for the expression of several markers of differentiating neurons (marker genes indicated to the left of panels) and compared to morphant embryos (F–J) and
embryos injected with sox3 mRNA at the 16–32 cell stage (K–O). (F–J) Morphant embryos show signiﬁcant disruption of all markers analysed. These are ngn1 (F, 27/42 embryos),
phox2a (G, 37/51), elavl3 (H, 9/11), elavl4 (I, 6/23) and nefm (J, 16/21). (K–O) Sox3 over-expression causes disruption of phox2a expression (L, indicated by asterisk), but does not
disrupt the expression of the other markers analysed, ngn1 (K, 9/32), elavl3 (M, 15/39), elavl4 (N, 14/28) and nefm (O, 3/19), which are all expressed strongly in regions of ectopic
neural tissue induced by Sox3 (indicated by arrows). (P–W) View of wild-type (P–S) and sox3 (16–32 cell) injected (T–W) embryos aged 18 hpf (P, T, S, W viewed laterally; Q, U, R,
V viewed dorsally). As at 24 hpf, Sox3 over-expression at this stage causes disruption of phox2a (U, 11/36), whilst ngn1 (T, 9/38), elavl3 (V, 18/39) and elavl4 (W, 6/26) are
expressed strongly in ectopic tissue (arrows). (X) Western blot using anti-HA showing that exogenous Sox3 protein has decreased dramatically by 18 hpf and is completely absent
by 24 hpf.
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Rentzsch et al., 2004) and has been shown in chick to be a rapid
response to ectopic Fgf (Streit et al., 2000), we set out to determine
whether Sox3 expression was able to compensate for loss of Fgf
signalling in zebraﬁsh. We ﬁrst treated ﬁsh with the inhibitor of FGF
signalling, SU5402, or DMSO alone as a negative control (from the 512
cell stage), with or without prior injection of Sox3 RNA at the 1–2 cell
stage. Embryos were then collected at mid-gastrulation (70% epiboly)
and examined for the expression of neural and non-neural markers.Inhibition of Fgf signalling resulted in a dramatic reduction of the
neural domain as marked by the expression of sox2 (Figs. 10A, B).
However, injection of Sox3 resulted in expansion of sox2 even in the
presence of SU5402 (Figs. 10C, D). Likewise, SU5402 alone caused a
dramatic expansion of gata2 expression (Figs. 10G, H) which was
repressed by Sox3 as it was with Sox3 alone (Figs. 10I, J). Although the
effects of Sox3 on sox2 and gata2 expression were not as strong in the
presence of SU5402, Sox3 does appear to be downstream of Fgf
signalling with respect to these genes and is able to rescue the effects
Fig. 9. Sox3 knock-down causes abnormal development of the ear and cranial placodes. All embryos are aged 24 hpf. Otic vesicles of control (A, arrow indicates otolith) and sox3
morphant (B–D) embryos showing reduced (B, 25/49 embryos), split (C, 10/49), or absent vesicles (D, 14/49). (E–H) In situ hybridisation of control (E) and sox3 morphant (F–H)
embryos viewed dorsally showing otic vesicles marked by the expression of pax2a again showing reduced (F), split (arrows, G) or absent (H) vesicles. (I, J) Lateral view showing
placodal expression of ngn1 in control (I) and sox3morphant embryos (J, 27/42). (K, L) Lateral view showing expression of phox2a in the epibranchial placodes of control (K) and sox3
morphant (L, 37/51) embryos. Expression of both ngn1 and phox2a is severely disrupted in the placodes of morphant embryos (J, L). ad, anterodorsal lateral line; av, anteroventral
lateral line; f, facial; o/g, octaval/statoacoustic/glossopharyngeal.
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relative levels of the sox3 versus SU5402. Higher levels of sox3 over-
expression could not be achieved in these experiments due to its
effects on mesoderm and gastrulation.
Due to the effects of Sox3 on gastrulation (Zhang et al., 2004) we
were unable to determine the effects of Sox3 on later stages of neural
development in similarly treated embryos. We therefore carried out
another series of experiments inwhichwe injected embryos with sox3
RNA at the 16–32 cell stage (together with GFP-encoding RNA) and
subsequently treated with SU5402 from the 512 cell stage until
collection at mid-gastrulation. This resulted in ectopic activation of
sox2 in a proportion of the sox3 over-expressing cells, and repression
of gata2, at mid-gastrulation (Figs. 10F, L) to a similar extent to that
seen with sox3 over-expression alone (Figs. 10E, K). However, by the 3
somite stage of development, the effect of Sox3 on neural fate, as
shown by expression of ncad or sox2, appeared to be lost in the
presence of SU5402 (Figs. 10P, T). Hence, it appears that Sox3 can
compensate for loss of Fgf signalling during the early stages of neural
tissue formation, but that Sox3 is not sufﬁcient to maintain this fate at
later stages.
Discussion
The data described in this study indicate a central role for Sox3 in
the establishment and subsequent development of the CNS. However,
the loss of Sox3 in morpholino-injected embryos also appears to
prevent differentiation and traps neural cells in an ncad/sox2 positive
state.We therefore propose that Sox3 plays a crucial role in connecting
the neural inducing signals of the early ectoderm to the establishment
of differentiated neurons.Sox3 and neural fate
We have shown that ectopic expression of Sox3 results in a
substantial increase in the population of cells adopting a neural fate.
This also results in disorganised structures, with multiple neural
epithelia either closely associated or seen as duplicated regions of the
CNS. In general, these additional neural elements are still ﬂanked by
neural crest and placodal domains, except where the domain of
ectopic Sox3 causes this lateral region to be entirely replaced by CNS
tissue. We have shown, using both injection and transplantation
experiments, that Sox3 is able to respecify cells of the ectoderm to a
neural fate in a cell autonomous manner and that this clearly has
consequences for the later development of the nervous system.
However, it is not yet clear to what extent the consequences of sox3
over-expression require the activity of additional factors, such asWnts
and Bmp antagonists. The details of this mechanism will need to be
tested by determining which other factors remain necessary for Sox3
to elicit these effects. Our data do not exclude the possibility that some
of the effects we see at later stages are the consequence of a non-
autonomous mechanism, which may explain some of the more
striking phenotypes we observe such as duplicated regions of the CNS.
A striking consequence of Sox3 over-expression is the frequent loss
of one or both eyes. This was previously observed inMedaka by Koster
et al. (2000) who interpreted this as some form of dominant-negative
effect. However, sox3 expression is lost in the retina in zebraﬁsh as
early as the 12 somite stage (Okuda et al., 2006) and at a similar stage
in Medaka (Koster et al., 2000) as it forms from the neural epithelium.
We therefore suggest that the loss of eye is a consequence of
continued sox3 expression inhibiting these cells from adopting the
specialized retinal fate, instead maintaining them as CNS neural
Fig. 10. Sox3 can expand neural fate in the early ectoderm in the absence of Fgf signalling, but requires Fgf to maintain neural fate at later stages. (A–L) Lateral view of mid-gastrula
stage embryos except for (K: Ventral view) and (L: Animal pole view). (A, G) Control embryos treated with DMSO only as a negative control for SU5402, showing expression of the
prospective neural marker sox2 (A) and the prospective non-neural marker gata2 (G). Treatment with the Fgf inhibitor, SU5402, causes repression of sox2 (B, 37/37 embryos) and
expansion of gata2 (H, 16/16). Injection of either DMSO treated (C, I) or SU5402 treated (D, J) embryos with sox3mRNA at the 1–2 cell stage caused expansion of sox2 (C, 18/18; D, 14/
19) and repression of gata2 (I, 7/17; J, 15/25). Injection of embryos with sox3 mRNA (and GFP mRNA lineage tracer) at the 16–32 cell stage caused ectopic expression of sox2 in a
proportion of the sox3 over-expressing cells (E, 7/7; F, 21/25) and repression of gata2 (K, 5/5; L, 9/17) in embryos treated with either DMSO (E, K) or SU5402 (F, L). (E–F, K–L)
Immunostaining of embryos for GFP (red colour) indicates the sox3 over-expressing region. (M–T) Embryos at the 3 somite stage viewed dorsally. (M, Q) DMSO treated control
embryos showing expression of neural markers ncad (M) and sox2 (Q). (N, R) SU5402 treatment causes repression of neural markers leaving only a small rostral region of neural plate.
Injection of sox3mRNA (and GFP mRNA) at the 16–32 cell stage causes expansion of the neural plate (O, 19/20; S, 9/9) in DMSO treated embryos (bars in panels Q and S indicate the
expansions of the neural plate), but by this stage has no effect on the expression of neural markers in SU5402 treated embryos (P, 25/25; T, 15/15). Arrows (P, T) indicate the region
expression exogenous Sox3 (red), showing that the neural markers ncad and sox2 are absent from this region.
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in eye formation. Loss of eyes was also observed in MO injected
embryos, which could be due to the general loss or disorganisation of
the cranial CNS resulting in disruption of the normal tissue
interactions that underlie formation of the optic cup.
The effects of depleting Sox3 through injection with MOs shed
light on its role in later development. Morphant ﬁsh exhibit an almost
complete lack of the normal expanded lumen in the brain. Studies in
chick have shown that brain growth is driven by closure of the anterior
neuropore and soon afterwards the closure, or ‘occlusion’, of the
neural tube just caudal to the hindbrain (reviewed by Desmond and
Levitan, 2002). Experimental disruption of the brain cavity in chick
embryos, causing loss of pressure, resulted in a 50% reduction in cell
number (Desmond and Jacobson,1977). However, although disruption
of CNS organisation resulting from our sox3MO injections does result
in lack of lumen expansion, this is unlikely to be the cause of the
substantial reduction in cell number we have observed in the brain,
since the cell number in the spinal cord is also reduced to a similar
degree, where occlusion does not normally play a role. Thus, it seems
more likely that the lack of an expanded lumen could be caused by the
physical disruption that results from the reduced size of the
neuroepithelium due to reduced cell numbers.It therefore seems that the reduced cell numbers in the CNS of
morphant ﬁsh are due to a cell autonomous effect of Sox3. However,
the presence ofmaternal Sox3 proteinmeans that Sox3 functionwould
be relatively normal at early stages of neural induction and this is likely
to explain why the effects we see on the size of the neural domain are
relatively mild. However, we do see a signiﬁcant reduction in neural
tissue, indicating that Sox3 plays a critical role that cannot be
compensated by the other SoxB1 protein, Sox2, that is co-expressed
with Sox3 at these later stages. This does not preclude some
redundancy between these proteins that might mask even more
severe effects were both proteins absent.
The precisemechanismbywhich loss of Sox3 results in reduced cell
number in the CNS remains unclear. Consistent with the altered fate
seenwhen Sox3was over-expressed, absence of Sox3 could result in an
altered fate choice such that cells that would have been fated to form
neural ectoderm instead form non-neural tissues. However, since the
effects of theMOs are only likely to impact oncematernal Sox3 protein
has degraded, this may be too late to inﬂuence such a fate. Given the
increased cell death seen in these morphant ﬁsh, it seems that this
reduction in size might be entirely due to cell loss through apoptosis.
Thus, the primary role of Sox3 could be in the maintenance of cells
committed to a neural fate, such that they cannot survive in its absence.
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Since Sox3 appears to play a central role in cells that develop as
neural ectoderm, how does it ﬁt into the complex signalling known to
control this fate? Sox3 expression is known to be dependent on Fgf
signalling in several species analysed (Dee et al., 2007; Heeg-Truesdell
and LaBonne, 2006; Kudoh et al., 2004; Rentzsch et al., 2004; Streit
and Stern, 1999). Our data show that Sox3 can compensate for loss of
Fgf signalling with respect to the regulation of early neural and non-
neural markers, but that the ‘neural’ tissue produced was not
maintained in the continued absence of Fgf signalling. Therefore,
Sox3 appears to act downstream of Fgf in the initial speciﬁcation of
neural ectoderm, but further Fgf-dependent processes, in addition to
Sox3 expression, are required for neural fate to be maintained.
These data extend previous observations in chick embryos. Streit et
al. (2000) showed that Fgf8 was sufﬁcient to induce ectopic
expression of Sox3, but Fgf signalling alone was insufﬁcient to induce
fully developed neural tissue in an ectopic position, suggesting that
other signals are needed to maintain its further development,
including the appearance of Sox2. Although our data suggest that
Sox3 can mediate the initial effects of Fgfs to induce early aspects of
neural fate in the ectoderm, further neural development is therefore
likely to require the activity of additional signalling pathways upon
those Sox3 positive cells. One possible reason why ectopic expression
of Sox3 was able to induce Sox2 expression in our zebraﬁsh
experiments (but Fgf-induced expression of sox3 did not achieve
this in the chick) might reﬂect the different timing and position of the
ectopic expression in the two studies. In the experiments of Streit et al.
(2000) in the chick, Fgf treatmentswere relatively late in development
by comparison to our zebraﬁsh experiments andmight also have been
more distant from sources of other signals involved in induction of the
endogenous nervous system. Since sox3 is broadly expressed
throughout the epiblast prior to neural induction in chick (Rex et al.,
1997), zebraﬁsh (Okuda et al., 2006) and Xenopus (Penzel et al., 1997),
these observations ﬁt with a model in which Sox3 endows cells with
the competence to respond to neural inducing signals. However, Sox3
is then maintained in the neural tissue that is induced and plays a role
in regulating neurogenesis, such that its maintained expression is also
an important component of the response to neural induction.
The role of Sox3 in placodal structures
In both the zebraﬁsh (Sun et al., 2007) and the chick (Abu-Elmagd
et al., 2001), we have previously shown that sox3 is expressed strongly
in the neurogenic placodes of the peripheral nervous system,
including the epibranchial and otic placodes. In this study, we have
presented evidence for an essential role of Sox3 in development of the
neurogenic placodes, acting downstream of Fgf signalling.
Fgf3 and Fgf8 have been shown to be crucial for the induction and
subsequent development of these placodal structures. Depletion of
either Fgf3 or Fgf8 results in the development of otic vesicles of
reduced size, whilst the depletion of both these signals together can
cause complete loss of otic vesicle (Phillips et al., 2001). More recently,
it has been shown that in addition to loss of sox3 expression (Sun et al.,
2007), embryos mutant for fgf3 and fgf8 do not express other markers
of the epibranchial placodes (Nechiporuk et al., 2007). Here, we have
shown that depletion of Sox3 expression caused reduction or loss of
otic vesicles, a similar disruption to that seenwhen Fgf3/8 signalling is
abolished. In addition, Sox3 knock-down caused a dramatic loss of
neurogenesis in the placodes as marked by ngn1 or phox2a. Since sox3
expression is Fgf-dependent and loss of Sox3 mimics loss of Fgf
signalling, this supports a model in which the activation of Sox3
expression is a key component of the machinery by which Fgf
signalling causes ectodermal cells to become competent to undergo
further neuronal development. We have also shown previously that
placodal sox3 expression requires expression of the forkheadtranscription factor foxi1, and an essential role for foxi1 in the
formation of the otic placode is well established (Solomon et al.,
2003; Sun et al., 2007). Certainly, the phenotypes reported for foxi1
loss-of-function, where a mutant allele (hearsay) or a foxi1 MO were
able to generate phenotypes very similar to thosewe have reported for
the sox3 morphant (Solomon et al., 2003), support a model in which
Sox3 plays a crucial role in the development of neurogenic placodes
acting downstream of Fgf signalling and Foxi1.
In the previous study of Koster et al. (2000), over-expression of
sox3 in Medaka was reported to cause the formation of ectopic otic
and lens structures, whilst also resulting in the disruption of
endogenous eye and ear development. We did ﬁnd over-expression
of sox3 could result in disrupted eye development (discussed earlier)
but we did not observe the induction of ectopic placodal tissues.
Although it is not clear why our data differ to this extent, we suggest
that these differing outcomes are likely to be due to signiﬁcant
differences in our technical approaches. However, our data support
the conclusion of Koster et al. (2000) that Sox3 is critical for early
development of placode derived organs.
Sox3 and neuronal differentiation
At later stages of development, we saw absence of overt neuronal
differentiation when Sox3 was knocked-down. The data of Bylund et
al. (2003) provided evidence that Sox3 normally acts to repress
neuronal differentiation in the chick spinal cord, but they did not
address to what extent Sox3 was necessary for cells to be able to
undergo that differentiation. We have shown that loss-of-function
results in the absence of markers including ngn1 expression. Since
neural tissue is present, this absence of neurogenesis is not simply due
to the effect of MO injection on the earlier formation and survival of
neural ectoderm. However, we cannot determine from these data, at
what stage in the process of neural development events have been
disrupted that caused this later absence of differentiating cells. The
instability of ectopic Sox3 compromises analysis of the ability of Sox3
over-expression to inhibit neurogenesis. We were not, therefore, able
to determine whether Sox3 has a similar effect in zebraﬁsh to the
inhibition of neurogenesis shown in chick (Bylund et al., 2003).
However, the effect on phox2a may represent an early respeciﬁcation
of the speciﬁc group of neurons that express this gene. Hence, it seems
that Sox3 plays a role in establishing the neural epithelium and is then
part of the machinery necessary for the transcriptional events that
initiate differentiation from those cells.
These data show that Sox3 plays unique roles in both the formation
and later differentiation of the neural epithelium and that its roles are
not compensated by the continued presence of other Sox family
members. The relative contribution of the other SoxB1 genes to these
aspects of neural development remains to be directly tested.
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